Kaiser Permanente's national infectious disease leader suggests the COVID-19 pandemic will transition into its “endemic” phase in 2022.
Stephen Parodi, MD, national infectious disease leader at Kaiser Permanente, stresses the importance of public health protective measures until the vaccine is broadly available for children under 5.
The Permanente Medical Group associate executive director says vaccination rates are above 96% for all Kaiser Permanente employees and 98% for Permanente physicians in California.
Kaiser Permanente’s national infectious disease leader says 99% of hospitalizations in California are among people who remain unvaccinated.
Kaiser Permanente infectious disease leader says physicians now have a huge task to restore confidence in vaccines.
The Permanente emergency medicine physician offers her first-hand account of addressing the COVID-19 pandemic across 8 states.
The Permanente pediatrician, a member of an FDA vaccine advisory panel, commented on how the recently approved Johnson & Johnson vaccine can aide in ending the pandemic.
Permanente infectious disease leader Stephen Parodi, MD, underscores the importance of the recently authorized 1-dose Johnson & Johnson vaccine in preventing hospitalizations and deaths.
Kaiser Permanente's national infectious disease leader says that the organization is working with the state and the federal government to inform them on COVID-19 vaccine supply needs.
Kaiser Permanente’s national infectious disease leader expressed confidence in the safety and efficacy of the vaccine, given the organization’s participation in Pfizer-BioNTech COVID-19 vaccine trials.